SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008310
Filing Date
2024-05-15
Accepted
2024-05-15 17:00:50
Documents
13
Period of Report
2024-05-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K capr-20240514x8k.htm   iXBRL 8-K 60425
  Complete submission text file 0001558370-24-008310.txt   178052

Data Files

Seq Description Document Type Size
2 EX-101.SCH capr-20240514.xsd EX-101.SCH 3122
3 EX-101.LAB capr-20240514_lab.xml EX-101.LAB 15268
4 EX-101.PRE capr-20240514_pre.xml EX-101.PRE 9656
16 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240514x8k_htm.xml XML 4682
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 24952307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)